Drug Enhancement Company of America Licenses Oculus' Microcyn(R) Technology for Use in First Responder ''Pen-Like'' Applicator Jun 13, 2007
Oculus Schedules Fiscal Fourth Quarter and Full Year 2007 Financial Results Release and Conference Call Jun 6, 2007
Oculus Initiates Patient Enrollment in Phase II Study of Microcyn(R) Technology for Treatment of Mild Diabetic Foot Infections May 21, 2007
Oculus Innovative Sciences Microcyn(R) Technology Presented in Poster at European Wound Management Association Conference May 14, 2007
China Bao Tai, Sinopharm and Lianhua Supermarkets to Distribute Oculus' Microcyn(R)-Based Wound Care Solution in China Apr 26, 2007
Oculus Announces Initial Sites for Phase II Clinical Trial of Microcyn(R) Technology in Treatment of Mild Diabetic Foot Infections Mar 29, 2007
Oculus' Dermacyn(R) Wound Care Subject of 33-Patient Study Published in International Journal of Lower Extremity Wounds Mar 13, 2007
